Jawad A Al-Lawati1, Prashanth Panduranga2, Hala A Al-Shaikh3, Magdi Morsi4, Nabil Mohsin5, Rajiv B Khandekar6, Hawra J Al-Lawati7, Riad A Bayoumi5. 1. Departments of Non-Communicable Disease Control, Ministry of Health, Muscat, Oman; 2. Department of Cardiology, Royal Hospital, Muscat, Oman; 3. Department of Paediatric Endocrinology, Muscat Private Hospital, Muscat, Oman; 4. Research, Ministry of Health, Muscat, Oman; 5. Department of Medicine, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman; 6. Department of Research, King Khalid Eye Specialist Hospital, Riyadh, Saudi Arabia; 7. Weill Cornell Medical College, Doha, Qatar.
Abstract
OBJECTIVES: This study aimed to describe the epidemiology of diabetes mellitus over the past two decades in Oman, particularly in terms of its prevalence and incidence. In addition, the study sought to estimate the future incidence of diabetes in Oman. METHODS: Three national and three regional surveys conducted between 1991 and 2010 were analysed to obtain the age-adjusted prevalence and undiagnosed proportion of type 2 diabetes mellitus (T2DM) among Omani subjects aged ≥20 years. Diabetes mellitus registers and published studies were used to determine incidence rates of both type 1 diabetes mellitus (T1DM) and T2DM in Oman. Linear regression was used to determine trends and projections for diabetes in 2050. RESULTS: The age-adjusted prevalence of T2DM in Oman varied from 10.4% to 21.1%, while the highest prevalence of impaired fasting glucose was found in males (35.1%). In comparison to men, higher incidence rates of T2DM were found in women (2.7 cases compared to 2.3 cases per 1,000 person-years, respectively). No significant trends were observed for the prevalence or incidence of T2DM in both genders. Undiagnosed T2DM was more common in men (range: 33-68%) than women (range: 27-53%). The results of this study show that by 2050, there will be an estimated 350,000 people with T2DM living in Oman (a 174% increase compared to estimates for 2015). CONCLUSION: Health authorities need to prioritise diabetes prevention and control in order to prevent or delay long-term complications and avert a potential epidemic of diabetes in Oman.
OBJECTIVES: This study aimed to describe the epidemiology of diabetes mellitus over the past two decades in Oman, particularly in terms of its prevalence and incidence. In addition, the study sought to estimate the future incidence of diabetes in Oman. METHODS: Three national and three regional surveys conducted between 1991 and 2010 were analysed to obtain the age-adjusted prevalence and undiagnosed proportion of type 2 diabetes mellitus (T2DM) among Omani subjects aged ≥20 years. Diabetes mellitus registers and published studies were used to determine incidence rates of both type 1 diabetes mellitus (T1DM) and T2DM in Oman. Linear regression was used to determine trends and projections for diabetes in 2050. RESULTS: The age-adjusted prevalence of T2DM in Oman varied from 10.4% to 21.1%, while the highest prevalence of impaired fasting glucose was found in males (35.1%). In comparison to men, higher incidence rates of T2DM were found in women (2.7 cases compared to 2.3 cases per 1,000 person-years, respectively). No significant trends were observed for the prevalence or incidence of T2DM in both genders. Undiagnosed T2DM was more common in men (range: 33-68%) than women (range: 27-53%). The results of this study show that by 2050, there will be an estimated 350,000 people with T2DM living in Oman (a 174% increase compared to estimates for 2015). CONCLUSION: Health authorities need to prioritise diabetes prevention and control in order to prevent or delay long-term complications and avert a potential epidemic of diabetes in Oman.
Authors: Ali H Mokdad; Sara Jaber; Muna I Abdel Aziz; Fadia AlBuhairan; Abduljabbar AlGhaithi; Nawal M AlHamad; Suad N Al-Hooti; Adel Al-Jasari; Mohammad A AlMazroa; Ahmed Mohamed AlQasmi; Shirina Alsowaidi; Majed Asad; Charles Atkinson; Alaa Badawi; Talal Bakfalouni; AbdelAziz Barkia; Stan Biryukov; Charbel El Bcheraoui; Farah Daoud; Mohammad Hossein Forouzanfar; Diego Gonzalez-Medina; Randah R Hamadeh; Mohamed Hsairi; Seifeddin Saleh Hussein; Nadim Karam; Shams Eldin Ali Hassan Khalifa; Tawfik A M Khoja; Faris Lami; Katherine Leach-Kemon; Ziad A Memish; Ali A Mokdad; Mohsen Naghavi; Jamal Nasher; M Bassam Hijawi Qasem; Mohammad Shuaib; Al Anoud M Al Thani; Mohamed H Al Thani; Mohammed Zamakhshary; Alan D Lopez; Christopher J L Murray Journal: Lancet Date: 2014-01-20 Impact factor: 79.321
Authors: A A Shaltout; M A Qabazard; N A Abdella; R E LaPorte; M al Arouj; A Ben Nekhi; M A Moussa; M A al Khawari Journal: Diabetes Care Date: 1995-07 Impact factor: 19.112
Authors: Sawsan Al-Sinani; Mohammed Al-Shafaee; Ali Al-Mamari; Nicholas Woodhouse; Omaima Al-Shafie; Mohammed Hassan; Said Al-Yahyaee; Sulayma Albarwani; Deepali Jaju; Khamis Al-Hashmi; Mohammed Al-Abri; Syed Rizvi; Riad Bayoumi Journal: Oman Med J Date: 2014-01
Authors: Prashanth Panduranga; Kadhim Sulaiman; Ibrahim Al-Zakwani; Aouf AbdlRahman Alazzawi; Abraham Abraham; Prit Pal Singh; Narayan Anantha Narayan; Mamatha Punjee Rajarao; Mohammed Ahmed Khdir; Mohamad Abdlraheem; Aftab Ahmed Siddiqui; Hisham Soliman; Osama Abdellatif Elkadi; Ruchir Kumar Bichu; Kumayl Hasan Al Lawati Journal: Oman Med J Date: 2016-05